Avalyn Pharma Inc. (AVLN) stock
AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.69−0.23 (-0.82%)
Close on Nov 18, 2026Market cap $1.23BP/E –Yield –
Avalyn Pharma shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Avalyn Pharma's shares outstanding was 30M at Jun 30, 2026.
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 30M | – |
| Q1 FY2026 | Mar 31, 2026 | 1M | – |
| Q2 FY2025 | Jun 30, 2025 | 1M | – |
| Q1 FY2025 | Mar 31, 2025 | 0M | – |
See a number that looks wrong?